Start with the transaction you are pricing
A pump rental month, a complete dressing change, a professional application service and a syringe award are different units. They also sit at different points in the payment chain. Comparing their dollar values without those distinctions can produce a bid that looks attractive on paper but fails the customer's actual purchasing model.
For a distributor supplying a Medicare billing supplier, a local allowable is a useful input to the customer's economics. For a hospital buying under its own contract, that same allowable may be background information. A UNICEF award is a useful reference for a comparable presentation and delivery term; it does not reveal the winning supplier's cost, profitability or willingness to serve another buyer at that price.
Build the comparison around five fields: the exact product or service, the billable or saleable unit, the buyer and care setting, the geography and effective period, and what the price includes. Only then place the public benchmark beside the supplier quotation. Keep taxes, freight, insurance, wastage, financing, distribution and service costs visible instead of hiding them in a single markup.
Medicare NPWT: locate the applicable schedule before calculating a margin
The July 2026 DMEPOS national file gives a reproducible snapshot for three familiar durable NPWT codes. E2402 RR is an electric pump rental; A6550 is the complete dressing set for a change; A7000 NU is a new disposable canister. The NPWT policy article describes the coding and required components. A reimbursement code is not a declaration that every product marketed with a similar name meets coverage or coding requirements. 19
| HCPCS | Item | Non-rural range (USD) | Non-rural median (USD) | Rural (USD) |
|---|---|---|---|---|
| E2402 RR | NPWT electrical pump, per rental month | 748.28 to 1,727.82 (continental max 881.94) | 829.21 | 1,504.41 |
| A6550 | NPWT dressing set, each | 31.08 to 37.54 | 31.67 | 33.70 |
| A7000 NU | Disposable canister for pump, each | 9.24 to 12.42 | 10.50 | 10.23 to 11.58 |
Unweighted summaries of 53 non-rural jurisdiction columns; separate former competitive bidding area schedules are not included.
- Method: E2402 RR, A6550 and A7000 NU without KE. Non-rural minimum/median/maximum include AK, HI, PR and VI. Rural zero entries for non-applicable columns excluded.
Source: CMS DMEPOS fee schedule, July 2026 — VEMERIX analysis, accessed September 2026
We calculated the non-rural minimum, median and maximum across 53 jurisdiction columns in the national file. Each jurisdiction receives equal weight; claims volume is not available in that calculation. Alaska, Hawaii, Puerto Rico and the Virgin Islands are included. The E2402 RR maximum is $1,727.82 across all columns, while the maximum among the contiguous states and District of Columbia is $881.94. Calling the latter a national maximum would exclude material geography. 1
The rural values also need their own scope. E2402 RR is $1,504.41 in the applicable populated rural columns; A6550 is $33.70. A7000 NU ranges from $10.23 to $11.58. Zero entries in non-applicable rural columns were excluded rather than treated as free supplies. We selected A7000 NU without the KE modifier; mixing modifier rows would change the question being answered. 1
The national file is not the complete universe of payable locality amounts. CMS publishes a separate former competitive bidding area file. For example, that file contains an E2402 RR amount of $946.62 for Aiken and an A6550 amount of $30.97 for Albuquerque. Those examples sit outside the corresponding contiguous-state maximum or national-file minimum above. The lesson is to select the beneficiary's applicable schedule and locality before using a benchmark in a quote. 12
An allowable is also not the same as the Medicare payment recorded in historical claims. Payment may depend on assignment, deductible, coinsurance, coverage and other claim circumstances. A commercial model must distinguish the allowed amount, expected collections and acquisition cost. The median A6550 amount of $31.67 alone cannot establish what a particular customer can profitably pay for a dressing. 4910
Surgical dressings: the code's size, border and billing unit matter
The fee file includes fields named ceiling and floor for surgical dressings. These are reimbursement calculation fields, not bounds on manufacturing cost. They should not be presented as a universal price corridor: non-continental payment rules can produce jurisdiction amounts outside those fields. For example, A6209 in Puerto Rico is $12.82 in this file, above its $10.65 ceiling field. 12
View chart data
| Category | Ceiling (USD) |
|---|---|
| Alginate ≤16 sq in (A6196) | 10.49 |
| Alginate >16–48 sq in (A6197) | 23.44 |
| Foam ≤16 sq in (A6209) | 10.65 |
| Foam >16–48 sq in (A6210) | 28.4 |
| Foam >48 sq in (A6211) | 41.86 |
| Foam adhesive ≤16 sq in (A6212) | 13.84 |
| Hydrocolloid ≤16 sq in (A6234) | 9.33 |
| Hydrocolloid >16–48 sq in (A6235) | 23.97 |
| Hydrocolloid >48 sq in (A6236) | 38.83 |
| Hydrogel ≤16 sq in (A6242) | 8.63 |
| Hydrogel >16–48 sq in (A6243) | 17.56 |
| Hydrogel >48 sq in (A6244) | 55.99 |
| Composite ≤16 sq in (A6203) | 4.8 |
| Specialty absorptive ≤16 sq in (A6251) | 2.84 |
| Sterile gauze ≤16 sq in (A6402) | 0.15 |
These are national file ceiling fields, not acquisition-price limits. Non-continental payable amounts can exceed them; full code descriptors appear below.
- Method: Ceiling amount per HCPCS code from the national fee schedule file.
Source: CMS DMEPOS fee schedule, July 2026 — VEMERIX analysis, accessed September 2026
The chart compares selected ceiling fields. It does not isolate the causal effect of material or absorption capacity on price. Codes differ in surface area, construction and border configuration, and a fee schedule is an administrative pricing system. For procurement, the useful next step is to match the quoted item to the full descriptor and intended use.
All 21 code summaries below were checked against the official July 2026 HCPCS file. Wound-cover sizes refer to the pad, not automatically the outside dimensions of an adhesive border. “Over 16 through 48” excludes 16 and includes 48. These are abbreviated purchasing references; the official descriptor remains the coding source. 11
| HCPCS | Verified descriptor summary and unit | Ceiling field, USD | Floor field, USD |
|---|---|---|---|
| A6196 | Sterile alginate or other fiber-gelling cover, pad ≤16 sq in, each | 10.49 | 8.92 |
| A6197 | Same cover, pad >16 through 48 sq in, each | 23.44 | 19.92 |
| A6199 | Sterile alginate or other fiber-gelling filler, per 6 inches | 7.52 | 6.39 |
| A6203 | Sterile composite cover, pad ≤16 sq in, any size adhesive border, each | 4.80 | 4.08 |
| A6209 | Sterile foam cover, no adhesive border, pad ≤16 sq in, each | 10.65 | 9.05 |
| A6210 | Same foam cover, pad >16 through 48 sq in, each | 28.40 | 24.14 |
| A6211 | Same foam cover, pad >48 sq in, each | 41.86 | 35.58 |
| A6212 | Sterile foam cover, pad ≤16 sq in, any size adhesive border, each | 13.84 | 11.76 |
| A6234 | Sterile hydrocolloid cover, no adhesive border, pad ≤16 sq in, each | 9.33 | 7.93 |
| A6235 | Same hydrocolloid cover, pad >16 through 48 sq in, each | 23.97 | 20.37 |
| A6236 | Same hydrocolloid cover, pad >48 sq in, each | 38.83 | 33.01 |
| A6242 | Sterile hydrogel cover, no adhesive border, pad ≤16 sq in, each | 8.63 | 7.34 |
| A6243 | Same hydrogel cover, pad >16 through 48 sq in, each | 17.56 | 14.93 |
| A6244 | Same hydrogel cover, pad >48 sq in, each | 55.99 | 47.59 |
| A6251 | Sterile specialty absorptive cover, no adhesive border, pad ≤16 sq in, each | 2.84 | 2.41 |
| A6402 | Sterile non-impregnated gauze, no adhesive border, pad ≤16 sq in, each | 0.15 | 0.13 |
| A6403 | Same gauze, pad >16 through 48 sq in, each | 0.58 | 0.49 |
| A6407 | Sterile non-impregnated packing strip, width ≤2 inches, per linear yard | 2.66 | 2.26 |
| A6442 | Non-elastic, non-sterile conforming bandage, width <3 inches, per yard | 0.23 | 0.20 |
| A6449 | Elastic light-compression bandage, width ≥3 and <5 inches, per yard | 2.50 | 2.13 |
| A6452 | Elastic high-compression bandage, width ≥3 and <5 inches, per yard; resistance ≥1.35 foot-pounds at 50% maximum stretch | 8.40 | 7.14 |
For a tender response, keep the supplied unit and billing unit in separate columns. A box price must be converted using its actual count; a roll cannot be compared with a per-yard fee without its usable length. Likewise, an adhesive-border product should not inherit the reference price of a borderless product just because the pad material matches. Clinical selection and coverage require their own review. 91011
Disposable NPWT: service counts and payment settings tell different stories
The CMS Medicare Physician & Other Practitioners dataset used here is by Geography and Service. The stored extract contains 20,830 rows across multiple procedures and geographies. The analysis uses only 88 national NPWT rows for 2013–2024; it does not treat all 20,830 rows as NPWT claims. Each row is an aggregate, not a patient or individual claim. 34
View chart data
| Category | Durable pump services (97605 + 97606) | Disposable services (97607 + 97608) |
|---|---|---|
| 2015 | 60385 | 1640 |
| 2016 | 61585 | 3181 |
| 2017 | 66666 | 4912 |
| 2018 | 69202 | 6340 |
| 2019 | 70082 | 7282 |
| 2020 | 66132 | 7620 |
| 2021 | 62457 | 9907 |
| 2022 | 55004 | 10091 |
| 2023 | 53746 | 12669 |
| 2024 | 53045 | 14176 |
Disposable-code services rose 8.64 times from 2015 to 2024; durable-code services fell 24.3% from 2019. Counts are services, not unique patients or device sales.
- Method: National total services summed across places of service; durable = 97605 + 97606; disposable = 97607 + 97608.
Source: CMS Medicare Physician & Other Practitioners — by Geography and Service; national rows, analysis September 5, 2026
Summing national total services across places of service, codes 97607 and 97608 increased from 1,640 services in 2015 to 14,176 in 2024: 8.64 times the initial count, or a 764.4% increase. Codes 97605 and 97606 fell from 70,082 services in 2019 to 53,045 in 2024, a 24.3% decline. These are historical billed services in this dataset. They do not count unique patients, units purchased, all Medicare NPWT activity or the share of wounds treated with each format. They cannot establish clinical substitution or an irreversible market transition. 3
Use service-weighted payments, then separate office and facility
To combine aggregate payment rows, multiply each row's average Medicare payment by its service count, sum those products and divide by total services. A simple mean of office and facility averages gives both settings equal weight regardless of their activity. For 97607, the 2024 service-weighted result is $135.46. 34
View chart data
| Category | 97607 (≤50 sq cm) | 97608 (>50 sq cm) |
|---|---|---|
| 2015 | 22.63 | 25.43 |
| 2016 | 22.76 | 24.82 |
| 2017 | 22.28 | 24.7 |
| 2018 | 22.7 | 25.76 |
| 2019 | 23.17 | 25.3 |
| 2020 | 70.14 | 43.77 |
| 2021 | 114.46 | 47.69 |
| 2022 | 150.54 | 56.69 |
| 2023 | 143.66 | 68.53 |
| 2024 | 135.46 | 69.79 |
National office and facility rows combined using service weights. Medicare payment excludes deductible and coinsurance; it is not a device purchase budget.
- Method: For each year/code: sum(total_services × avg_medicare_payment) / sum(total_services); round only final result to cents.
Source: CMS Medicare Physician & Other Practitioners — by Geography and Service; national rows, analysis September 5, 2026
| Code | 2024 services | Service-weighted Medicare payment, USD | Office average, USD | Facility average, USD |
|---|---|---|---|---|
| 97607 | 11,815 | 135.46 | 258.00 | 16.37 |
| 97608 | 2,361 | 69.79 | 257.27 | 19.29 |
For 97607, the totals comprise 5,823 office and 5,992 facility services. For 97608, they comprise 501 office and 1,860 facility services. The wide setting difference is commercially relevant, but neither the combined average nor the office value is a stand-alone device acquisition budget. CMS's payment measure excludes beneficiary deductible and coinsurance; it is not the full allowed amount or total provider revenue. 34
The time series also cannot attribute the 2020 increase solely to a shift in setting mix. The office average for 97607 itself rose from $37.37 in 2019 to $218.52 in 2020 in the stored data. Explaining that discontinuity requires the relevant annual payment rules and coding context, beyond the descriptive comparison here. 3
Home health has a separate device-payment route
Do not carry the professional-claims chart directly into a home-health budget. Effective January 1, 2024, CMS instructs home health agencies to bill qualifying disposable NPWT devices using HCPCS A9272 on type of bill 032x. Nursing and therapy services remain paid under the home health prospective payment system. The earlier use of CPT 97607/97608 on type of bill 034x, with an OPPS-based payment, describes the pre-2024 method. 12
The new device payment starts from the physician fee schedule supply-price basis and follows the specified annual adjustment rules. It does not turn the historical professional payment average into a home-health device rate. The DME policy's treatment of A9272 must also be read within that benefit: it cannot support a claim that disposable NPWT is never covered anywhere in Medicare. Establish the provider type, benefit, bill type, service date and applicable device before quoting an expected reimbursement. 912
UNICEF awards: compare the same year, presentation and delivery term
UNICEF's published long-term arrangement tables are unusually useful procurement evidence because they identify products, suppliers, years and terms. The tables span many years, however, and a number printed beside a supplier is not necessarily a 2026 price. We re-extracted the 2026 column from each PDF and checked its page position. Blank cells were excluded rather than filled with historical awards. 5613
View chart data
| Category | Minimum 2026 award | Maximum 2026 award |
|---|---|---|
| 0.5 ml AD syringe | 0.0225 | 0.0388 |
| 0.05 ml AD syringe | 0.0246 | 0.044 |
| 2 ml RUP syringe | 0.0254 | 0.0531 |
| 5 ml RUP syringe | 0.0232 | 0.0588 |
| 10 ml RUP syringe | 0.0352 | 0.054 |
| 1 ml RUP syringe | 0.0324 | 0.0324 |
Ranges reflect listed 2026 product/FCA rows. The 1 ml RUP selection has one price; historical prices and blank cells are excluded.
- Method: Minimum and maximum of populated 2026 USD cells in the AD and RUP PDFs. Separate supplier and row counts appear in the article. Prices are awards, not manufacturing costs.
Source: UNICEF Supply Division price data — VEMERIX analysis, accessed September 2026
| Presentation | 2026 USD range per unit | Distinct listed suppliers | Priced product/FCA rows |
|---|---|---|---|
| 0.5 ml AD syringe | 0.0225–0.0388 | 9 | 12 |
| 0.05 ml AD syringe | 0.0246–0.0440 | 3 | 5 |
| 2 ml RUP syringe | 0.0254–0.0531 | 5 | 8 |
| 5 ml RUP syringe | 0.0232–0.0588 | 7 | 10 |
| 10 ml RUP syringe | 0.0352–0.0540 | 3 | 4 |
| 1 ml RUP syringe | 0.0324 | 1 | 1 |
| 5 litre safety box, USD awards | 0.5212–0.8600 | 6 | 9 |
A further 5 litre safety-box row is priced at EUR 0.3752 from PaHu Oy. It remains separate; combining it with USD observations without a stated exchange rate would create a false minimum. Across both currencies, the 2026 safety-box selection comprises seven suppliers and ten rows. 13
The syringe minima in this selection are Wuxi rows with China FCA locations. Several maxima are KD Medical rows with Morocco FCA locations even though the supplier's listed legal location is Germany. A supplier address, delivery location and customs origin are three different fields. None should silently substitute for another in a tariff model. 56
The tables describe FCA prices for containerized sea shipments under the arrangements and identify conditions such as discounts or surcharges. They do not include every cost of delivering goods to a destination hospital. Price spreads may reflect multiple contractual and product differences; this dataset does not isolate the contribution of a safety mechanism, origin or production technology. A quote below the observed range is not, by itself, evidence of unsafe manufacture, material substitution or impending default. 5613
Use the award range to form a comparable quotation request. Specify capacity, needle presentation, reuse-prevention characteristics, packaging quantities, delivery location, order volume, shelf life on arrival and the requested term. Then ask the supplier to identify deviations. The public price is the reference; the comparable specification and delivery conditions determine whether it is useful.
Use WHO specifications as a starting document, with version control
The reuse-prevention syringe sheet reviewed for this report belongs to WHO's technical specifications for 13 devices on the UN life-saving commodities list, not the separate collection of 61 medical devices. Its September 2013 version is a historical procurement template. Its activation field permits automatic or elective approaches and single or multiple aspirations, depending on the product specification. Its listed syringe standards include ISO 7886-1 and ISO 7886-4. 14
That document does not establish that every RUP syringe must have the same activation design, or that ISO 7886-2 and ISO 23908 are requirements cited by this particular sheet. Current applicable standards, editions and tender requirements must be checked for the actual device. GMDN and UNSPSC references help describe and classify an item; they are not substitutes for regulatory authorization. 14
A practical specification matrix should separate the buyer's functional requirement, the supplier's exact design, the applicable current standard or regulatory requirement, and the evidence supplied. Mark each row as demonstrated, clarification needed or not applicable with a reason. This keeps a familiar acronym from becoming a claim of compliance without a matching document.
For NPWT dressings, ask for the product's intended use, compatible system identification, complete set contents and relevant performance and sterility documentation. The CMS coding definition can help define a billable set, but it does not prove compatibility with a particular pump. VEMERIX's dressing classification guide provides related market-access questions; product-specific classification and test evidence still have to be established. 915
Tariffs: a Free general rate does not mean a duty-free entry
USITC's tariff schedule must be read with the current Chapter 99 measures, origin rules and any applicable exclusions. The selected headings below are a starting reference for classification review, not an assignment of a code to a reader's product. A composite NPWT kit, for example, needs its own analysis of components and presentation. 16
| HTS heading | Description for orientation | General rate | 2024 action: China-origin component |
|---|---|---|---|
| 9018.31.00 | Syringes, with or without needles | Free | 100%; temporary enteral treatment ended January 1, 2026 |
| 9018.32.00 | Tubular metal needles; suture needles | Free | 100% from September 27, 2024 |
| 9018.39.00 | Catheters, cannulae and similar | Free | Check applicable Chapter 99 measures |
| 3005.10.10 / 3005.10.50 | Selected adhesive dressings | Free | Check applicable Chapter 99 measures |
| 3005.90.10 / 3005.90.50 | Selected other dressings, gauze and bandages | Free | Check applicable Chapter 99 measures |
| 3006.10.01 | Selected surgical sutures and related goods | Free | Check applicable Chapter 99 measures |
| 4015.12.10 | Medical and surgical rubber gloves | Free | 100% from January 1, 2026 |
Free is the general rate in these selected headings. Current Chapter 99 duties and exceptions must be checked separately; these rows do not classify an individual product.
- Method: Selected general rates and the 2024 product-specific Section 301 component. The separate July 2026 forced-labor layer is not included in the last column.
Source: USITC HTS 2026; September 18, 2024 Section 301 modification; CBP July 23, 2026 guidance
The September 2024 Section 301 modification raised the additional China-origin duty on syringes under 9018.31.00 and needles under 9018.32.00 to 100%, effective September 27, 2024. The temporary enteral-syringe treatment ended at the start of 2026. Medical and surgical gloves under 4015.12.10 moved to 50% in 2025 and 100% in 2026 under the same action. These percentages describe that particular measure. 7
The 2026 update is material: CBP's July 23 guidance implements a separate forced-labor Section 301 action effective July 24. It lists China under 9903.05.31 at an additional 12.5%, except for products described in the specified exception headings. A 100% product-specific rate therefore cannot be advertised as the complete current tariff burden. Whether both layers apply to a particular entry requires the current classification and exception checks. 817
| Effective date / status | Measure | Scope relevant to this report |
|---|---|---|
| September 27, 2024 | Technology-transfer Section 301 modification | China-origin syringes and needles: 100% component |
| January 1, 2025 | Glove phase-in under the 2024 action | Selected China-origin medical gloves: 50% component |
| January 1, 2026 | Glove step and enteral-syringe exclusion expiry | Selected gloves reach 100%; enteral syringes enter the 100% component |
| July 24, 2026 | Forced-labor Section 301 action | China: additional 12.5% under 9903.05.31, subject to listed exceptions |
| Investigation notice, September 2025 | Medical products Section 232 investigation | A proceeding to monitor; the notice itself sets no duty rate |
A measure-specific percentage is not the total entry duty. The July 2026 China-origin layer carries its own exceptions.
- Method: Primary-source effective dates and measure scopes; no inferred rate from an investigation.
Source: Federal Register, September 18, 2024; CBP CSMS #69326983, July 23, 2026; BIS investigation notice, September 26, 2025
For illustration, a 100% duty component on a $50,000 customs value is $50,000. That arithmetic is not a delivered-cost quotation: it excludes other applicable duties, customs fees, freight and downstream costs. It also does not mean that every line in the landed-cost calculation doubles. Keep each applicable duty component and its legal basis as a separate row.
The medical-device Section 232 investigation is another issue to monitor. The investigation notice establishes a proceeding; it does not, by itself, establish a payable tariff rate. This dated benchmark report is not a customs-entry instruction. A bid validity clause should identify who rechecks classification, origin, exclusions and effective dates before shipment, and who bears an intervening duty change. 1819
A bid worksheet that preserves the meaning of each number
The worksheet below is a suggested commercial process, not a formula derived from CMS or UNICEF. It keeps a reimbursement reference distinct from a procurement award and leaves transaction-specific costs for the actual quotation.
| Quoted line | Public reference | Scope to resolve | Inputs from the actual transaction |
|---|---|---|---|
| NPWT complete dressing set | A6550: $31.67 unweighted non-rural median in national file | Applicable benefit, code eligibility, modifier, locality and service date; device compatibility | Acquisition cost per complete set, delivery/service costs, coverage documents, item-specific customs review |
| 2 ml RUP syringe | UNICEF 2026 awards: $0.0254–$0.0531 per unit, FCA | Exact presentation, needle, packaging, volume, term, shelf life and destination requirements | Comparable supplier quote, responsible manufacturer, current evidence, origin and full entry duties |
Fill transaction-specific cost and regulatory fields before setting a bid. No public manufacturing-cost floor is inferred.
- Method: Illustrative workflow, not an empirically validated pricing rule.
Source: VEMERIX proposed worksheet; CMS July 2026 DMEPOS file and UNICEF 2026 RUP award column
For each line, calculate acquisition cost in the saleable unit, then add the applicable freight, insurance, duties, fees, quality-release costs and expected wastage. Allocate financing, service and overhead according to the business's own accounting method. Compare the resulting contribution at the proposed sale price with the required return and the customer's purchasing constraints.
If a team uses gross margin, define it consistently as revenue less the relevant cost of goods sold, divided by revenue. Do not confuse it with markup, which divides the same difference by cost. State which costs are included before comparing margins across suppliers or product lines. Public schedules cannot supply the missing assumptions.
Before submitting, resolve these parallel checks:
- Product and unit: Does the quote match the required device, presentation, pack count, dimensions and usable quantity?
- Payment context: If reimbursement is relevant, which benefit, code, modifier, setting, locality and date apply?
- Comparable award: Does the UNICEF reference match the year, currency, delivery term and specification closely enough to be informative?
- Landed cost: Is there an entry-specific classification and origin review, including all current duty layers and exceptions?
- Evidence and contract: Are the required regulatory, quality, compatibility and supply documents available, and are delivery responsibilities and change clauses explicit?
Where VEMERIX can support the next step
VEMERIX presents a minimally invasive surgery and perioperative product platform. Its public product pages and a product-specific technical pack are the appropriate starting point for a sourcing enquiry. A reimbursement code or international award does not establish that a listed VEMERIX product is interchangeable with another manufacturer's device, or that VEMERIX manufactures every system it offers. 20
For a distributor or OEM enquiry, bring the intended market, product specification, expected volume, delivery term and documentation requirements. Request an itemized commercial scope, identification of the responsible manufacturer, and the applicable registration and quality evidence. The contract manufacturing buyer guide adds a supplier-evaluation framework; the benchmark tables here supply separate pricing context. 21
Methodology and limitations
This analysis prioritizes the stored R2 datasets and verifies decision-sensitive rules against primary public sources. DMEPOS values come from the July 2026 national fee file, with a separate check of the former competitive bidding area file. The 53-column median is unweighted. Rural non-applicable zero entries are excluded; code and modifier selections are retained in the working analysis. All 21 dressing summaries were rechecked against the July HCPCS file. 1211
The professional-claims calculation filters national geography rows for 97605–97608, checks uniqueness by year, code and place of service, sums services, and weights average payments by those service counts. The source covers historical fee-for-service professional activity and has its own disclosure and scope limits. It is not a census of all NPWT use. 34
UNICEF observations come only from populated 2026 cells in the cited AD, RUP and safety-box PDFs. Distinct supplier counts are separate from product/FCA row counts. Currency is not mixed. The AD and safety-box documents were updated in October 2025; the RUP document was updated in January 2026. Those document dates are not replaced by the September analysis date. 5613
The stored Comtrade extract was rejected because its reporter field was empty throughout; it cannot support country-specific trade conclusions. This report therefore makes no trade-volume ranking. WHO's historical template and the tariff measures are used only within their stated scope. The chart data, filters, corrected payment formula, rejected-source record and publication checks are retained with the research package. Readers should recheck time-sensitive schedules and entry treatment for the date of their own transaction.
